HIV & AIDS
New insights into HIV virus shed light on how it evades immune surveillance
About 36 million people have died from AIDS-related illnesses and approximately 38 million people globally are living with HIV.
May 25, 2022
0
26
Sorted by date
Medications
Lenacapavir reduces viral load in multidrug-resistant HIV-1 infection
Patients with multidrug-resistant HIV-1 infection receiving the capsid inhibitor lenacapavir have a greater reduction in viral load than those receiving placebo, according to a study published in the May 12 issue of the New ...
May 12, 2022
0
12
HIV & AIDS
Decline in the number of people diagnosed with HIV in New Zealand
The number of people being diagnosed with HIV in New Zealand continues to decline, figures released today by the University of Otago's AIDS Epidemiology Group show.
May 12, 2022
0
3
HIV & AIDS
Antibody dependent cellular cytotoxicity may help prevent HIV transmission from mother to child during breastfeeding
According to new research from Boston Medical Center, the antibody function known as antibody dependent cellular cytotoxicity (ADCC) and the ADCC sensitivity of HIV strains may influence the transmission of HIV from mother ...
Apr 20, 2022
0
29
HIV & AIDS
Antibody therapy controls HIV for months in new clinical trial
Antiretroviral therapy has made HIV a manageable condition, but it does not eliminate the virus from the body—and most regimens are expensive and require a pill every day, for the rest of the patient's life.
Apr 19, 2022
0
28
HIV & AIDS
The antibodies of 'post-treatment HIV controllers'
A very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding the fundamental mechanisms that ...
Apr 14, 2022
0
266
HIV & AIDS
Protease inhibitors safer than previously thought for pregnant women with HIV
University of Oxford researchers assessed evidence from 34 studies, involving more than 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of ...
Apr 12, 2022
0
30
HIV & AIDS
Sequencing HIV proviruses from people on antiretroviral therapy using droplet-microfluidics
The infection of human immunology viruses (HIV) occurs by integrating its genome into infected cells to enter an inactive state of reversible latency that evades anti-retroviral therapy. The capacity to sequence such a provirus ...
HIV & AIDS
New approach for delivery of anti-HIV antibody therapy shows promise in phase I clinical trial
Since the first reports of HIV infection in the early 1980s, multiple clinical trials have tested potential vaccines against the virus, but unfortunately, HIV has numerous defense mechanisms that prevent a person's immune ...
Apr 11, 2022
0
58
HIV & AIDS
Climate change reduces HIV treatment adherence in Africa
Droughts caused by climate change can have an impact on HIV treatment, according to a new study led by researchers at Brighton and Sussex Medical School (BSMS), Africa Health Research Institute (AHRI) and the University of ...
Apr 11, 2022
0
9
